INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
137 hedge funds and large institutions have $556M invested in Infinity Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
-4
Holders Change %
-2.84%
% of All Funds
3.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
59
Reduced
44
Closed
21
Calls
$3.56M
Puts
$3.07M
Net Calls
+$482K
Net Calls Change
-$1.39M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$20.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.92M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.94M |
| 4 |
Renaissance Technologies
New York
|
+$5.81M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.21M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$16.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$12.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$7.43M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$6.13M |
| 5 |
Millennium Management
New York
|
-$4.76M |
